Clinical trial Recruiting at 1 site Phase 3 Interventional Ages 18 to 43 Women only

Pentoxifylline to improve uterine lining and frozen embryo transfer outcomes

Official title: Effect of Pentoxyfilline on Endometrial Thickness and Frozen Embryo Transfer Outcomes

Run by Beni-Suef University · NCT07499817 · Data updated 2026-11-12

This trial sees if giving pentoxifylline alongside standard estradiol helps women with good-quality day‑5 frozen embryos get a thicker uterine lining and better frozen embryo transfer success.

More Infertility trials

Quick facts

PhasePhase 3
Study typeInterventional
Ages18 Years to 43 Years
SexWomen only
Enrollment100 (estimated)
SponsorBeni-Suef University
Academic / other
Locations1 site (Banī Suwayf, Beni Suweif Governorate)
StatusRecruiting
StartedOctober 1, 2023
Main results expectedApril 1, 2026
Study endsApril 30, 2026
Registry record updatedMarch 30, 2026
Trial IDNCT07499817 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women about 18–43 years old with unexplained infertility who have good-quality day‑5 frozen embryos and no endocrine, significant cardiac/renal/hepatic disease or prior endometrial‑compromising surgery.

Probably not a fit

Patients with known endocrine disorders, significant cardiovascular/renal/hepatic disease, prior surgery that compromised the endometrium, or those not using day‑5 frozen embryos are unlikely to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This Phase 3 randomized, parallel study enrolled 100 women aged 18–43 with good-quality day‑5 frozen embryos and unexplained infertility, randomized 1:1 to estradiol alone or estradiol plus pentoxifylline 400 mg daily. Endometrial thickness was measured by transvaginal ultrasound and frozen embryo transfer outcomes (implantation and pregnancy rates) were recorded. Treatment began on cycle day 1 and continued until the day progesterone was started; allocation used computer-generated randomization with sealed opaque envelopes. Patients with endocrine disease, prior surgeries that could compromise the endometrium, or significant cardiovascular, renal, or liver disease were excluded.

Why it matters

Potential benefit: If successful, adding pentoxifylline could increase endometrial thickness and improve implantation and pregnancy rates for women having frozen embryo transfers.

How similar studies have gone: Smaller prior studies of pentoxifylline and other vasodilators for endometrial thickness have reported mixed results, so the approach has some precedent but is not definitively proven.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* as good quality day five frozen embryos.

Exclusion Criteria:

* history of endocrine diseases,
* history of any previous surgery that couldm compromise the integrity of endometrium,
* cardiovascular, renal and liver diseases,

Where it's running

  • Beni-suef university Hospital
    Banī Suwayf, Beni Suweif Governorate, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.